Financhill
Sell
17

PAVM Quote, Financials, Valuation and Earnings

Last price:
$0.28
Seasonality move :
-27.86%
Day range:
$0.28 - $0.30
52-week range:
$0.27 - $0.90
Dividend yield:
0%
P/E ratio:
0.30x
P/S ratio:
256.11x
P/B ratio:
0.94x
Volume:
155K
Avg. volume:
403.6K
1-year change:
-56.18%
Market cap:
$7.9M
Revenue:
$3M
EPS (TTM):
-$0.57

Earnings Data

Next earnings date for PAVM
Mar 24
2026
Most recent earnings per share
-$0.29
Missed by $0.09
(Nov 13/2025)
Consensus Estimate
-$0.20
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PAVM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/24/2026 Q4 -- -- -- -$0.15 --
11/13/2025 Q3 $12.5K $5K -$0.29 -$0.20 -$0.09
08/14/2025 Q2 $10K $6K -$0.74 -$0.25 -$0.49
05/12/2025 Q1 $10K $8K $0.34 -$0.29 $0.63
03/25/2025 Q4 $20K $10K $0.12 -$0.40 $0.52
11/14/2024 Q3 $1.1M $996K $1.44 -$1.30 $2.74
08/13/2024 Q2 $1.2M $979K -$1.19 -$1.34 $0.15
05/14/2024 Q1 $1M $1M -$2.62 -$1.55 -$1.07
03/27/2024 Q4 $1M $1M -$1.94 -$1.79 -$0.15
11/14/2023 Q3 $658K $791K -$2.38 -$2.10 -$0.28
08/16/2023 Q2 $525K $166K -$2.10 -$2.33 $0.22
05/17/2023 Q1 -- $446K -$2.78 -- --
03/14/2023 Q4 -- $112K -$3.26 -- --
11/15/2022 Q3 -- $76K -$4.38 -- --
08/15/2022 Q2 -- -- -$4.42 -- --
05/12/2022 Q1 -- $189K -$2.94 -- --
03/29/2022 Q4 -- $300K -$3.00 -- --
11/16/2021 Q3 -- $200K -$2.21 -- --
08/12/2021 Q2 -- -- -$2.11 -- --
05/17/2021 Q1 -- -- -$1.93 -- --
02/22/2021 Q4 -- -- -$2.56 -- --
11/17/2020 Q3 -- -- -$1.72 -- --
08/18/2020 Q2 -- -- -$1.89 -- --
04/09/2020 Q1 -- -- -$5.02 -- --
12/31/2019 Q4 -- -- -$2.85 -- --
11/21/2019 Q3 -- -- -$1.52 -- --
09/05/2019 Q2 -- -- -$1.99 -- --
04/04/2019 Q1 -- -- -$1.99 -- --
12/31/2018 Q4 -- -- -$3.81 -- --
11/15/2018 Q3 -- -- -$1.87 -- --
08/14/2018 Q2 -- -- -$3.99 -- --
04/11/2018 Q1 -- -- -$3.10 -- --
12/31/2017 Q4 -- -- $0.32 -- --
11/15/2017 Q3 -- -- -$6.00 -- --
08/14/2017 Q2 -- -- -$1.17 -- --
03/31/2017 Q1 -- -- -$4.80 -- --
02/22/2017 Q4 -- -- -$1.95 -- --
12/07/2016 Q3 -- -- -$2.10 -- --
08/17/2016 Q2 -- -- -$1.48 -- --
03/31/2016 Q1 -- -- -$0.79 -- --
12/31/2015 Q4 -- -- -$0.82 -- --

PAVmed, Inc. Earnings Questions

  • How Much did PAVmed, Inc. Generate in Revenue Last Quarter?

    PAVmed, Inc. reported $5K worth of top line sales in its most recent quarter.

  • Did PAVmed, Inc. Beat Earnings Last Quarter?

    PAVmed, Inc. announced earnings per share of -$0.29 which represents a miss of analyst forecast a -$0.20 per share.

  • Is PAVmed, Inc. Profitable?

    PAVmed, Inc. reported -$72K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for PAVmed, Inc. EPS Next Year?

    PAVmed, Inc.'s earnings are forecast to decrease from $0.50 per share to -$2.69 per share next year representing a decrease of -70.65%.

  • When is PAVmed, Inc.'s Earnings Date?

    PAVmed, Inc.'s next earnings date is March 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock